USPTO serial 79408511
Serial No. 79408511
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 2, 2025
- Examiner
- BROWN, TINA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79408511?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
National Institutes of Biomedical Innovation, Health and Nutrition
JP
Other trademarks owned by National Institutes of Biomedical Innovation, Health and Nutrition
National Institutes of Biomedical Innovation, Health and Nutrition
JP
Other trademarks owned by National Institutes of Biomedical Innovation, Health and Nutrition
National Institutes of Biomedical Innovation, Health and Nutrition
JP
Other trademarks owned by National Institutes of Biomedical Innovation, Health and Nutrition
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tsan Abrahamson
Tsan Abrahamson Cobalt LLP1912 Bonita AvenueBerkeley, CA 94704United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells, cancer cells, and genetically engineered T-cells for research purposes; stem cells, other than for medical and veterinary purposes; biological tissue cultures, other than for medical and veterinary purposes; nucleic acid sequences, other than for medical and veterinary purposes; serum samples for scientific purposes; assay samples for research purposes; cultures of microorganisms, other than for medical and veterinary purposes; chemicals, namely, enzymes for scientific and research purposes, reagents for scientific and research purposes, cell membrane integrity dyes for scientific or research purposes, fluorescent dye for scientific or research use, buffer solutions for use in analytical chemistry, and biomarker testing agents in the nature of biomarker reagents for research purposes | ACTIVE | — |
| 005 | Cells for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; nucleic acid sequences for medical and veterinary purposes; blood serums for medical purposes; blood plasma; crude medicines, namely, medicinal roots, unprocessed seeds for medical use, traditional medicines made of animal glands, mineral supplements, and mineral preparations for medical purposes; medicinal herbs; cultures of microorganisms for medical purposes | ACTIVE | — |
| 009 | Laboratory apparatus and instruments, namely, laboratory centrifuges, laboratory pipettes, research laboratory blood chemistry analyzers, laboratory incubators, laboratory microscopes; phonograph records featuring information in the field of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; downloadable music files; downloadable image files containing images and information in the field of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; recorded video discs and video tapes featuring information in the field of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; Downloadable electronic publications in the nature of newsletters, press releases, brochures, magazines, journals, books, and pamphlets in the fields of health and nutrition, exercise, wellness, diet, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; Electronic publications, namely, newsletters, press releases, brochures, magazines, journals, books, and pamphlets in the fields of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development recorded on computer media | ACTIVE | — |
| 016 | Printed matter, namely, journals, books, magazines, newsletters, press releases, brochures, and pamphlets in the field of health and nutrition, diet, exercise, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; Printed matter, namely printed calendars | ACTIVE | — |
| 030 | Dried cooked rice | ACTIVE | — |
| 031 | Seed germ for botanical purposes, namely, unprocessed cereal seeds, unprocessed seeds for agricultural use; live plants; live laboratory animals; live animals; eggs for hatching, fertilized; seeds and bulbs, namely, seeds and bulbs for planting, plant seeds, bulbs for agricultural purposes; spores and spawn for agricultural purposes; saplings; seedlings | ACTIVE | — |
| 035 | Compilation of information into computer databases; systemization of information into computer databases; updating and maintenance of data in computer databases | ACTIVE | — |
| 041 | Educational services, namely, providing classes, seminars, and workshops relating to arts, craft, sports and general knowledge in the field of health and wellness, exercise, diet, nutrition, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development and instruction services relating to arts, crafts, sports and general knowledge in the field of health and wellness, exercise, diet, nutrition, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; arranging, conducting and organization of seminars in the fields of health and wellness, exercise, diet, nutrition, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; providing online non-downloadable electronic publications in the nature of newsletters, press releases, brochures, magazines, journals, books, and pamphlets in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; providing videos from the internet, not downloadable in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development | ACTIVE | — |
| 042 | Scientific research for medical purposes; culturing of cells for scientific research purposes; preparation of biological samples for research purposes, namely, testing, analysis and evaluation blood and tissue samples for scientific and medical research purposes for use in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; scientific research, testing and analysis services, namely, biomedical research testing and analysis, infectious diseases research testing and analysis, immunology research testing and analysis, epidemiology research testing and analysis, cancer research testing and analysis, vaccine research testing and analysis, and drug research and testing analysis; consultancy relating to scientific research; provision of information and data relating to scientific research and development and technological research and development, namely, research and development of technology in the field of health and nutrition, exercise, diet, wellness, biomedical research, infectious diseases, immunology, epidemiology, cancer research, vaccine research and development, and drug research and development; product development; consultancy relating to product development; providing information in the field of product development; research in the field of artificial intelligence technology; development and testing of computing methods, algorithms and software; computer software design, computer programming, and maintenance of computer software; testing, inspection and research of pharmaceuticals, cosmetics and foodstuffs; testing and research on machines, apparatus and instruments; providing computer programs on data networks, namely, providing on-line non-downloadable software for use in controlling and managing patient medical information, and providing information and advice relating thereto; providing computer programs on data networks, namely, providing on-line non-downloadable software for use in medical diagnosis, medical testing and medical treatment, and providing information and advice relating to thereto; hosting computer databases, namely, hosting computer websites featuring databases, hosting of digital content on the Internet in the nature of databases; hosting platforms on the Internet, namely, providing platform as a service (PAAS) services featuring computer software platforms for use in controlling and managing patient medical information, and providing information and advice relating thereto; hosting platforms on the Internet, namely, providing platform as a service (PAAS) services featuring computer software platforms for use in medical diagnosis, medical testing and medical treatment, and providing information and advice relating to thereto | ACTIVE | — |
| 044 | Plant nursery services; cultivation of plants for others; consultancy relating to the cultivation of plants; human tissue bank services; stem cell bank services; blood bank services; cultured cell bank services for medical transplantation; collection and preservation of human blood; medical analysis services relating to the treatment of persons; laboratory animal breeding; stud services for animals; in vitro fertilization services for animals; providing medical information; dietary and nutritional guidance; animal breeding | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by National Institutes of Biomedical Innovation, Health and Nutrition
- Other trademarks owned by National Institutes of Biomedical Innovation, Health and Nutrition
- Other trademarks owned by National Institutes of Biomedical Innovation, Health and Nutrition
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 030
- Other trademarks in Class 031
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 5, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jun 5, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 16, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 30, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 29, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 2, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 2, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 2, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 14, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 14, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 17, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 14, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 14, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 8, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 6, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 6, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 31, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |